I call the meeting back to order.
I'd like to welcome our second panel of witnesses for today. We have a couple of witnesses participating remotely, so I will just inform the committee that, in accordance with our routine motion, all remote participants have completed the required connection tests in advance of the meeting.
For our remote participants, you will see on the bottom of your screen that you have the choice of floor, English or French. That's to be able to access the simultaneous translation, should you require it.
Here are the witnesses we have with us today. From JDRF Canada, we have Jessica Diniz, president and CEO.
Ms. Diniz, thank you for your patience as we worked through the technical issues. We're going to start with you.
From the Association québécoise des pharmaciens propriétaires, we have Benoit Morin, president, and Geneviève Pelletier, senior director, external and pharmaceutical affairs.
Representing the Canadian Association of Retired Persons, we have Bill VanGorder, chief policy officer, appearing by video conference. On behalf of Diabetes Canada, we have Glenn Thibeault, executive director, government affairs, advocacy and policy.
Welcome back, Mr. Thibeault. It's good to see you again.
We also have Russell Williams, senior vice-president, mission. Representing the Smart Health Benefits Coalition, we have Carolyne Eagan, principal representative.
We're going to begin with opening statements in the order listed on the notice of meeting. We're going to start with JDRF Canada.
Ms. Diniz, welcome to the committee. You have the floor.